Paper38742
Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens.
Rahal JJ and 1 other. Antimicrob Agents Chemother, 1979. Cited by 166 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bactericidal and bacteriostatic action of chloramphenicol against memingeal pathogens. Papers, record 38742. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38742
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chloramphenicol | Major topic |
| Haemophilus influenzae | Major topic |
| Meningitis | Major topic |
| Neisseria meningitidis | Major topic |
| Streptococcus pneumoniae | Major topic |
| Ampicillin | |
| Enterobacteriaceae | |
| Phagocytosis | |
| Staphylococcus aureus | |
| Sulfisoxazole | |
| Tetracycline |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1,086,634 | Susceptibility of Haemophilus influenzae type b to cefatrizine, ampicillin, and chloramphenicol. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/1086634 | PubMed |
| 2 | 1,103,620 | Gram-negative bacillary meningitis. | Am J Med | 1975 | https://conductscience.org/library/papers/1103620 | PubMed |
| 3 | 13,301 | Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. | N Engl J Med | 1977 | https://conductscience.org/library/papers/13301 | PubMed |
| 4 | 13,942,741 | Studies on the pathogenesis of meningitis. III. Relationship of phagocytosis to the fall in cerebrospinal fluid sugar in experimental pneumococcal meningitis. | J Lab Clin Med | 1963 | https://conductscience.org/library/papers/13942741 | PubMed |
| 6 | 19,357 | Classical and alternative complement pathway activation by pneumococci. | Infect Immun | 1977 | https://conductscience.org/library/papers/19357 | PubMed |
| 7 | 24,668 | Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. | J Infect Dis | 1978 | https://conductscience.org/library/papers/24668 | PubMed |
| 8 | 300,110 | A comparison of chloramphenicol and ampicillin as bactericidal agents for Haemophilus influenzae type B. | J Med Microbiol | 1977 | https://conductscience.org/library/papers/300110 | PubMed |
| 9 | 306,090 | Effect of ampicillin and chloramphenicol against Haemophilus influenzae. | Pediatrics | 1978 | https://conductscience.org/library/papers/306090 | PubMed |
| 10 | 402,433 | Quantitative relationships of the fourth complement component in human cerebrospinal fluid. | J Lab Clin Med | 1977 | https://conductscience.org/library/papers/402433 | PubMed |
| 11 | 4,345,082 | Treatment of gram-negative bacillary meningitis in adults. | Ann Intern Med | 1972 | https://conductscience.org/library/papers/4345082 | PubMed |
| 12 | 4,594,162 | Phagocytosis (third of three parts). | N Engl J Med | 1974 | https://conductscience.org/library/papers/4594162 | PubMed |
| 13 | 4,951,944 | Cerebrospinal fluid immunoglobulins in bacterial meningitis. A possible role for antibody in pneumococcal meningitis. | Arch Neurol | 1971 | https://conductscience.org/library/papers/4951944 | PubMed |
| 14 | 599,185 | Cerebrospinal fluid immunoglobulins and complement in meningococcal meningitis. | J Clin Pathol | 1977 | https://conductscience.org/library/papers/599185 | PubMed |
| 15 | 65,561 | A new type of penicillin resistance of Staphylococcus aureus. | Lancet | 1977 | https://conductscience.org/library/papers/65561 | PubMed |
| 16 | 8,756 | Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. | Pediatrics | 1976 | https://conductscience.org/library/papers/8756 | PubMed |
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,643,409 | Cooperative antibiotic resistance in bacteria: beyond biofilms. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42643409 | PubMed |
| 42,337,479 | A complex case of piperacillin-tazobactam resistant Elizabethkingia anophelis neonatal meningitis: the challenge of treatment and literature review. | BMC Pediatr | 2026 | https://conductscience.org/library/papers/42337479 | PubMed |
| 42,073,283 | Rapid Optical Nanomotion-Based Antibiotic Susceptibility Testing of Kombucha-Associated Acetic Acid Bacteria and Escherichia coli. | Foods | 2026 | https://conductscience.org/library/papers/42073283 | PubMed |
| 41,892,406 | Persistent Gaps in the Ultimate Mechanisms of Antimicrobial-Induced Bacterial Killing. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/41892406 | PubMed |
| 40,689,788 | Static vs. cidal: it's not complex; it's simply incorrect. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40689788 | PubMed |
| 40,221,737 | Antibacterial properties of silver and gold nanoparticles synthesized using Cannabis sativa waste extract against Pseudomonas aeruginosa. | J Cannabis Res | 2025 | https://conductscience.org/library/papers/40221737 | PubMed |
| 39,471,409 | Bactericidal versus bacteriostatic antibacterials: clinical significance, differences and synergistic potential in clinical practice. | J Antimicrob Chemother | 2025 | https://conductscience.org/library/papers/39471409 | PubMed |
| 38,817,674 | Bacillus subtilis produces (p)ppGpp in response to the bacteriostatic antibiotic chloramphenicol to prevent its potential bactericidal effect. | mLife | 2022 | https://conductscience.org/library/papers/38817674 | PubMed |
| 38,343,999 | Bimetallic nanoparticle production using Cannabis sativa and Vitis vinifera waste extracts. | RSC Adv | 2024 | https://conductscience.org/library/papers/38343999 | PubMed |
| 37,808,183 | Optimizing tylosin dosage for co-infection of Actinobacillus pleuropneumoniae and Pasteurella multocida in pigs using pharmacokinetic/pharmacodynamic modeling. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37808183 | PubMed |
| 37,279,202 | The Pioneer platform: A novel approach for selection of selective anti-cancer cytotoxic activity in bacteria through co-culturing with engineered human cells. | PLoS One | 2023 | https://conductscience.org/library/papers/37279202 | PubMed |
| 36,830,271 | Hydrocinnamic Acid and Perillyl Alcohol Potentiate the Action of Antibiotics against Escherichia coli. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36830271 | PubMed |
| 36,830,107 | Trend of Changes in Chloramphenicol Resistance during the Years 2017-2020: A Retrospective Report from Israel. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36830107 | PubMed |
| 35,806,919 | Sepsis Management in Southeast Asia: A Review and Clinical Experience. | J Clin Med | 2022 | https://conductscience.org/library/papers/35806919 | PubMed |
| 35,161,424 | Silver Nanoparticle Production Mediated by Vitis vinifera Cane Extract: Characterization and Antibacterial Activity Evaluation. | Plants (Basel) | 2022 | https://conductscience.org/library/papers/35161424 | PubMed |
| 35,113,894 | Development of an efficient antimicrobial susceptibility testing method with species identification by Nanopore sequencing of 16S rRNA amplicons. | PLoS One | 2022 | https://conductscience.org/library/papers/35113894 | PubMed |
| 33,758,186 | Translation error clusters induced by aminoglycoside antibiotics. | Nat Commun | 2021 | https://conductscience.org/library/papers/33758186 | PubMed |
| 33,537,056 | Metagenomic Approaches to Analyze Antimicrobial Resistance: An Overview. | Front Genet | 2020 | https://conductscience.org/library/papers/33537056 | PubMed |
| 33,083,729 | Cytosolic Crowding Drives the Dynamics of Both Genome and Cytosol in Escherichia coli Challenged with Sub-lethal Antibiotic Treatments. | iScience | 2020 | https://conductscience.org/library/papers/33083729 | PubMed |
| 32,823,501 | A Quantitative Survey of Bacterial Persistence in the Presence of Antibiotics: Towards Antipersister Antimicrobial Discovery. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32823501 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38742
GET https://conductscience.org/api/papers/v1/38742/cited_by?page=2